Bora Gari̇pcan
Papers
1
Total Citations
16
H-Index
1
About
Bora Garipcan is a leading figure in the field of nanobiotechnology and targeted drug delivery, with a particular focus on developing intelligent, bioinspired systems for cancer therapy. His most cited work, "Paclitaxel-conjugated phenylboronic acid-enriched catalytic robots as smart drug delivery systems" (2022, 16 citations), exemplifies his innovative approach to creating autonomous, catalytic micro- and nanorobots that can navigate biological environments and release therapeutic agents with high precision. By integrating phenylboronic acid chemistry with paclitaxel, Garipcan has pioneered a strategy for responsive drug release, leveraging the unique pH and glucose sensitivities of tumor microenvironments. This work not only demonstrates a novel method for enhancing chemotherapeutic efficacy but also addresses critical challenges in drug targeting and controlled release. His contributions are pivotal in advancing the next generation of smart drug delivery vehicles, bridging the gap between synthetic nanomotors and clinical oncology. With a growing citation record, Garipcan’s research is increasingly recognized for its potential to transform personalized medicine, offering a blueprint for designing multifunctional, self-propelling therapeutic platforms that could significantly improve patient outcomes in cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1